Flared ostial endoprosthesis and delivery system
An intraluminal endoprosthesis having a conically shaped first end and a tubular shaped balloon-expandable stent for a main body is disclosed. The conically shaped first end may form a flare to the main body and is particularly well suited for in ostium use. The first end is preferably self-expanding and the main body is preferably balloon-expandable. Also disclosed is a delivery device for delivering intraluminal ostial endoprosthetic devices, especially those disclosed herein, to a site for deployment. The delivery device may comprise an over-the-wire system or may comprise a rapid-exchange shuttle system. The self-expanding portion of the endoprosthesis is encapsulated in a sheath or other restraining apparatus on the delivery device. The balloon-expandable stent portion of the endoprosthesis is crimped onto a balloon delivery device. The delivery system and endoprosthesis of the present invention allow the endoprosthesis to be partially expanded and relocated if it is determined that it is not located in the proper location. To aid in positioning, the delivery device may comprise marker bands.
1. An intraluminal endoprosthesis comprising:
a first component that is a self-expanding stent, the self-expanding-stent component, when expanded, having a flared portion;
a second component, separated from the first component, that is a balloon-expandable stent; and
a connecting membrane at least partially covering the self-expanding-stent component and the balloon-expandable-stent component and thereby providing a connection between the separate balloon-expandable-stent component and the self-expanding-stent component; wherein, when it is deployed, the self expanding stent component has an outer edge with a radius greater than the expanded radius of the balloon expandable stent component; and wherein the outer end of the self expanding stent component forms hooks.
2. The endoprosthesis of claim 1 , wherein the membrane acts as a drug delivery platform.
3. The endoprosthesis of claim 1 , wherein exposed sections thereof act as a delivery platform for therapeutic agents.
4. The endoprosthesis of claim 1 , wherein the membrane is a fluoropolymer.
5. The endoprosthesis of claim 1 , wherein the membrane is erodible.
6. The endoprosthesis of claim 1 , wherein the membrane is manufactured from PTFE.
7. The endoprosthesis of claim 1 , wherein the self-expanding-stent component is manufactured from NiTi.
8. The endoprosthesis of claim 1 , wherein the self-expanding-stent component is manufactured from spring stainless steel.
9. The endoprosthesis of claim 1 , wherein the balloon-expandable-stent component comprises a plurality of helical segments.
10. An intraluminal endoprosthetic device comprising:
a first, self-expanding end, the self-expanding end forming a generally cone-shaped portion when the endoprosthesis is deployed;
a second end having a square edge;
a tubular balloon-expandable stent body disposed between the second end and the first, self-expanding end and separated from the first end; and
an encapsulating material that serves to connect the first, self-expanding end and the separate balloon-expandable stent body to each other; wherein the first self expanding end has a flared portion; wherein the flared portion forms hooks.
11. The endoprosthesis of claim 10 , further comprising a transition region between the stent body and the square end.
12. The endoprosthesis of claim 10 , wherein the hooks form compound angles.
13. The endoprosthesis of claim 10 , wherein the encapsulated portion of the self-expanding end is formed prior to mounting the endoprosthesis in a delivery catheter.